Moderna, Inc. (MRNA)
USD 25.23
(-1.95%)
USD 25.23
(-1.95%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.57 Billion USD | -32.12% |
| 2022 | 6.73 Billion USD | -36.0% |
| 2021 | 10.52 Billion USD | 120.38% |
| 2020 | 4.77 Billion USD | 1051.77% |
| 2019 | 414.61 Million USD | -4.0% |
| 2018 | 431.9 Million USD | -5.94% |
| 2017 | 459.19 Million USD | -20.18% |
| 2016 | 575.31 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.96 Billion USD | 1.43% |
| 2024 Q1 | 3.91 Billion USD | -14.44% |
| 2023 Q1 | 5.26 Billion USD | -21.87% |
| 2023 FY | 4.57 Billion USD | -32.12% |
| 2023 Q4 | 4.57 Billion USD | -23.74% |
| 2023 Q3 | 5.99 Billion USD | 21.48% |
| 2023 Q2 | 4.93 Billion USD | -6.21% |
| 2022 Q1 | 10.53 Billion USD | 0.1% |
| 2022 FY | 6.73 Billion USD | -36.0% |
| 2022 Q4 | 6.73 Billion USD | -16.48% |
| 2022 Q3 | 8.06 Billion USD | 0.07% |
| 2022 Q2 | 8.05 Billion USD | -23.5% |
| 2021 Q3 | 10.79 Billion USD | 14.29% |
| 2021 Q4 | 10.52 Billion USD | -2.55% |
| 2021 FY | 10.52 Billion USD | 120.38% |
| 2021 Q1 | 8.85 Billion USD | 85.45% |
| 2021 Q2 | 9.44 Billion USD | 6.7% |
| 2020 Q3 | 1.89 Billion USD | 250.77% |
| 2020 FY | 4.77 Billion USD | 1051.77% |
| 2020 Q2 | 539.12 Million USD | 26.36% |
| 2020 Q1 | 426.66 Million USD | 2.91% |
| 2020 Q4 | 4.77 Billion USD | 152.52% |
| 2019 FY | 414.61 Million USD | -4.0% |
| 2019 Q4 | 414.61 Million USD | 22.27% |
| 2019 Q3 | 339.09 Million USD | -2.2% |
| 2019 Q2 | 346.72 Million USD | -3.73% |
| 2019 Q1 | 360.17 Million USD | -16.61% |
| 2018 Q4 | 431.9 Million USD | 4.65% |
| 2018 FY | 431.9 Million USD | -5.94% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q2 | 452.91 Million USD | 0.0% |
| 2018 Q3 | 412.72 Million USD | -8.87% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 459.19 Million USD | 0.0% |
| 2017 FY | 459.19 Million USD | -20.18% |
| 2016 FY | 575.31 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -1261.622% |
| Alkermes plc | 933.53 Million USD | -389.75% |
| Agenus Inc. | 462.29 Million USD | -888.979% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | -12.874% |
| Aptorum Group Limited | 5.25 Million USD | -86874.089% |
| Ardelyx, Inc. | 130.76 Million USD | -3396.402% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -855.706% |
| Bicycle Therapeutics plc | 224.41 Million USD | -1937.324% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -3411.251% |
| ChromaDex Corporation | 26.5 Million USD | -17147.623% |
| Chimerix, Inc. | 19.74 Million USD | -23055.229% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -12897.086% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -6200.384% |
| CRISPR Therapeutics AG | 346.76 Million USD | -1218.461% |
| Precision BioSciences, Inc. | 140.92 Million USD | -3144.394% |
| Dyadic International, Inc. | 2.34 Million USD | -195230.274% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -28012.894% |
| Fortress Biotech, Inc. | 165.93 Million USD | -2655.229% |
| Lantern Pharma Inc. | 2.73 Million USD | -166780.682% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -6296.195% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -129465.211% |
| Incyte Corporation | 1.59 Billion USD | -187.137% |
| IO Biotech, Inc. | 17.55 Million USD | -25942.379% |
| Jaguar Health, Inc. | 45.86 Million USD | -9868.168% |
| Novavax, Inc. | 2.57 Billion USD | -77.742% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -12579.572% |
| Opthea Limited | 264.6 Million USD | -1627.883% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -3397.9% |
| ContextLogic Inc. | 206 Million USD | -2119.417% |
| MiMedx Group, Inc. | 96.33 Million USD | -4646.185% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -9420.636% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -129459.263% |
| NextCure, Inc. | 14.99 Million USD | -30386.097% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -113012.321% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -68373.866% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -9681.981% |
| Vaxcyte, Inc. | 167.44 Million USD | -2630.384% |
| PDS Biotechnology Corporation | 33.25 Million USD | -13646.6% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -1843.762% |
| Pharming Group N.V. | 244.07 Million USD | -1773.21% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -38249.27% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -3477.717% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -69096.412% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -69096.412% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -5446.322% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -68724.326% |
| Acelyrin, Inc. | 86.35 Million USD | -5194.547% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -351797.762% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -31696.37% |
| Summit Therapeutics Inc. | 125.25 Million USD | -3550.095% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -48132.936% |
| Senti Biosciences, Inc. | 52.57 Million USD | -8596.81% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -6547.571% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -2917.583% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -233642.331% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -342227.286% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -1915.589% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -48709.651% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -1910.156% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -824.553% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -41791.149% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -16518.807% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -37670.456% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -839.579% |
| Immix Biopharma, Inc. | 3.72 Million USD | -122744.346% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -11991.4% |
| MEI Pharma, Inc. | 8.35 Million USD | -54621.724% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -15657.367% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -1215.381% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -3034.319% |
| Fortress Biotech, Inc. | 165.93 Million USD | -2655.229% |
| Precigen, Inc. | 41.64 Million USD | -10878.772% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -9056.82% |
| AlloVir, Inc. | 45.01 Million USD | -10056.614% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -3407.83% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -3217.852% |
| ImmuCell Corporation | 18.81 Million USD | -24199.729% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -16097.832% |
| Onconetix, Inc. | 23.18 Million USD | -19623.144% |
| PureTech Health plc | 125.58 Million USD | -3540.62% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -50983.799% |
| Elevation Oncology, Inc. | 34.28 Million USD | -13236.445% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -186893.865% |
| Seer, Inc. | 39.36 Million USD | -11514.378% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -7293.99% |
| Innoviva, Inc. | 568.55 Million USD | -704.148% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -16691.538% |
| ESSA Pharma Inc. | 3.49 Million USD | -130712.793% |
| GlycoMimetics, Inc. | 6.9 Million USD | -66140.959% |
| GT Biopharma, Inc. | 6.63 Million USD | -68828.087% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -1629.264% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -1579.111% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -5341.173% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -46677.164% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -16728.003% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -141633.47% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -6097.893% |
| Aptose Biosciences Inc. | 15.8 Million USD | -28820.782% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -41314.221% |
| Soligenix, Inc. | 7.27 Million USD | -62746.19% |
| Century Therapeutics, Inc. | 175.94 Million USD | -2498.598% |
| Kura Oncology, Inc. | 51.66 Million USD | -8749.832% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -3669.727% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -110521.824% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -69027.612% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -1709.991% |
| Autolus Therapeutics plc | 263.9 Million USD | -1632.428% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -43517.63% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -5045.114% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -9648.609% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -1195.713% |
| GRI Bio, Inc. | 2.69 Million USD | -169421.691% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -564633.783% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -14605.22% |
| IGM Biosciences, Inc. | 220.17 Million USD | -1976.511% |
| INmune Bio, Inc. | 18.86 Million USD | -24139.211% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -1682.602% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -17060.995% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -168086.798% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -139278.941% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -7721.401% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -4654.625% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -1627.01% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -455.509% |
| Verastem, Inc. | 71.18 Million USD | -6322.701% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -9197.218% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -11751.314% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -9243.579% |
| Histogen Inc. | 5.69 Million USD | -80152.765% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -104150.155% |
| Surrozen, Inc. | 8.14 Million USD | -56032.597% |
| Organovo Holdings, Inc. | 2.74 Million USD | -166275.546% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -1456609.722% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -8030.906% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -27588.953% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -8846.637% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -552825.17% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -3507.812% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -42180.131% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -2930.042% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -175250.788% |
| Apollomics, Inc. | 14.15 Million USD | -32204.105% |
| Amarin Corporation plc | 279.58 Million USD | -1535.269% |
| Mesoblast Limited | 188.79 Million USD | -2321.636% |
| Turnstone Biologics Corp. | 14.14 Million USD | -32215.522% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -2428.929% |
| Synaptogenix, Inc. | 5.52 Million USD | -82584.251% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -68672.563% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -2587.704% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -53328.735% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -260058.086% |
| Exelixis, Inc. | 678.44 Million USD | -573.894% |
| Better Therapeutics, Inc. | 23.84 Million USD | -19076.244% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -2687.023% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -669.426% |
| NLS Pharmaceutics AG | 10.68 Million USD | -42708.171% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -281493.677% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -11645.061% |
| Gritstone bio, Inc. | 125.91 Million USD | -3530.906% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -31052.903% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -89747.419% |
| Avid Bioservices, Inc. | 275.66 Million USD | -1558.517% |
| Insmed Incorporated | 1.66 Billion USD | -175.13% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -59322.742% |
| MediWound Ltd. | 27.18 Million USD | -16716.861% |
| OmniAb, Inc. | 87.4 Million USD | -5131.121% |
| Alector, Inc. | 487.66 Million USD | -837.521% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -1033.209% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -24714.111% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -11814.627% |
| Zai Lab Limited | 240.17 Million USD | -1803.596% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -625.647% |
| Aura Biosciences, Inc. | 29.22 Million USD | -15543.07% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -4708.734% |
| Immunic, Inc. | 25.36 Million USD | -17922.706% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -6503.501% |
| Veracyte, Inc. | 93.71 Million USD | -4778.413% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -174625.692% |
| FibroGen, Inc. | 585.72 Million USD | -680.567% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -26201.559% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -699971.661% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -80742.259% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 40.285% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -55669.7% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -5341.432% |
| TG Therapeutics, Inc. | 169.08 Million USD | -2603.965% |
| Galecto, Inc. | 5.89 Million USD | -77444.098% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -55090.729% |
| Fortrea Holdings Inc. | 2.61 Billion USD | -74.61% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -15762.883% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -36125.339% |
| XBiotech Inc. | 8.39 Million USD | -54348.017% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -31052.903% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -8497.217% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -1159.136% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -16906.398% |
| Theravance Biopharma, Inc. | 169 Million USD | -2605.261% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -276.111% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -813.622% |
| Vaxxinity, Inc. | 30.94 Million USD | -14675.078% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -370.134% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -75706.979% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -513.499% |
| NexImmune, Inc. | 5.08 Million USD | -89825.086% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -1230937.658% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -148590.277% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 35.67% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -88607.283% |
| Scopus BioPharma Inc. | 7.45 Million USD | -61232.624% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -17287.997% |
| Ainos, Inc. | 7.39 Million USD | -61732.055% |
| Pluri Inc. | 34.11 Million USD | -13302.908% |
| Prothena Corporation plc | 135.01 Million USD | -3286.24% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -1780.684% |
| Celularity Inc. | 102.92 Million USD | -4341.897% |
| Rallybio Corporation | 9.43 Million USD | -48352.734% |
| Cue Biopharma, Inc. | 24.44 Million USD | -18603.211% |
| MeiraGTx Holdings plc | 319.99 Million USD | -1328.79% |
| Omeros Corporation | 403.25 Million USD | -1033.782% |
| Humacyte, Inc. | 114.67 Million USD | -3886.85% |
| Immunocore Holdings plc | 228.15 Million USD | -1903.875% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -93684.615% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -5857.78% |
| Blueprint Medicines Corporation | 918.64 Million USD | -397.692% |
| CalciMedica, Inc. | 4.02 Million USD | -113405.462% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -26097.57% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -2866.077% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -5227.616% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -1545.83% |
| Pulmatrix, Inc. | 15.96 Million USD | -28541.233% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -28886.242% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -18480.834% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -1722.908% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -8902.479% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -277.652% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -14285.049% |
| Nutriband Inc. | 1.07 Million USD | -423657.483% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -42898.213% |
| Vor Biopharma Inc. | 59.1 Million USD | -7635.517% |
| Roivant Sciences Ltd. | 773.95 Million USD | -490.734% |
| Evogene Ltd. | 17.99 Million USD | -25314.119% |
| ProKidney Corp. | 29.21 Million USD | -15548.959% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -6251.853% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -648426.277% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -142.044% |
| CorMedix Inc. | 11.91 Million USD | -38263.661% |
| BioLineRx Ltd. | 50.7 Million USD | -8917.396% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -2959.033% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -5069.548% |
| Atai Life Sciences N.V. | 49.16 Million USD | -9199.866% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -14576.281% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -25353.736% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -3568.282% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -80763.106% |
| MediciNova, Inc. | 3.89 Million USD | -117385.23% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -24912.309% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -303840.658% |
| GeoVax Labs, Inc. | 3.51 Million USD | -129790.755% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -1050.886% |
| Biomea Fusion, Inc. | 30.69 Million USD | -14797.361% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | -67.981% |
| Mereo BioPharma Group plc | 15.96 Million USD | -28543.027% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -14553.376% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -7690.88% |
| Absci Corporation | 58.3 Million USD | -7741.658% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -23902.52% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -14159.872% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -6095.962% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -5126.158% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -13438.644% |
| Allakos Inc. | 74.79 Million USD | -6012.872% |
| Imunon, Inc. | 8.53 Million USD | -53496.379% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -20219.097% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -3882.162% |
| BioAtla, Inc. | 48.98 Million USD | -9233.279% |
| NLS Pharmaceutics AG | 10.68 Million USD | -42708.171% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -164419.611% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -3400.658% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -32063.208% |
| XOMA Corporation | 145.58 Million USD | -3040.541% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -13480.87% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -6549.311% |
| aTyr Pharma, Inc. | 31.59 Million USD | -14369.728% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -7295.306% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -10067.908% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -9345.891% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -159203.136% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -55943.024% |
| Akari Therapeutics, Plc | 4.58 Million USD | -99638.22% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -25682.251% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -177.181% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1131840.937% |
| UroGen Pharma Ltd. | 243.52 Million USD | -1777.441% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -1323.913% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -165458.717% |
| Orgenesis Inc. | 35.53 Million USD | -12766.188% |
| Entera Bio Ltd. | 1.37 Million USD | -331444.598% |
| GH Research PLC | 6.7 Million USD | -68128.623% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -67135.294% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -24185.563% |
| Xencor, Inc. | 283.55 Million USD | -1512.363% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -153031.201% |
| Replimune Group, Inc. | 113.21 Million USD | -3938.37% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -121588.791% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -4316.111% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1131840.937% |
| Portage Biotech Inc. | 4.45 Million USD | -102641.573% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -303840.658% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -19735.141% |
| OncoCyte Corporation | 49.29 Million USD | -9174.21% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -110420.075% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -573203.038% |
| Purple Biotech Ltd. | 10 Million USD | -45597.151% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -78918.32% |
| scPharmaceuticals Inc. | 57.26 Million USD | -7884.492% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -36806.621% |
| HilleVax, Inc. | 78.9 Million USD | -5694.016% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -90434.653% |
| Tharimmune, Inc. | 1.81 Million USD | -251794.442% |
| Genprex, Inc. | 3.25 Million USD | -140395.014% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -16759.029% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -87218.564% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -2219317.476% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -1275043.077% |
| OKYO Pharma Limited | 7.42 Million USD | -61510.226% |
| Savara Inc. | 37.19 Million USD | -12192.966% |
| Curis, Inc. | 57.61 Million USD | -7835.847% |
| Daré Bioscience, Inc. | 26.32 Million USD | -17264.319% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -11563.327% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -316520.499% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -21860.709% |
| BeiGene, Ltd. | 2.23 Billion USD | -104.679% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -21375.073% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -1642.398% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -21391.022% |
| Erasca, Inc. | 78.61 Million USD | -5715.98% |
| bluebird bio, Inc. | 424.62 Million USD | -976.717% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -697646.821% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -141.898% |
| DBV Technologies S.A. | 42.8 Million USD | -10582.243% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -697646.821% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -65260.972% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -275986.957% |
| Molecular Templates, Inc. | 31.17 Million USD | -14567.479% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -26683.831% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -677.415% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -3572.142% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -16563.629% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -12441.145% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -8117.848% |
| MacroGenics, Inc. | 154.2 Million USD | -2864.846% |
| RenovoRx, Inc. | 4.46 Million USD | -102273.489% |
| Adicet Bio, Inc. | 37.12 Million USD | -12216.81% |
| Prime Medicine, Inc. | 60.78 Million USD | -7422.211% |
| Aditxt, Inc. | 28.53 Million USD | -15924.362% |
| Adagene Inc. | 45.16 Million USD | -10021.91% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -2530046.485% |
| Quantum-Si incorporated | 26.63 Million USD | -17067.962% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -555.422% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -150174.221% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -3877.001% |
| SciSparc Ltd. | 1.59 Million USD | -286545.768% |
| Vericel Corporation | 127.7 Million USD | -3480.126% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -82057.899% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -5256.258% |
| Generation Bio Co. | 171.63 Million USD | -2563.87% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -39484.416% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -10829.693% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -1709.274% |
| Invivyd, Inc. | 51.71 Million USD | -8741.104% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -4870.808% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -70181.685% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -5955.95% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -447696.278% |
| 2seventy bio, Inc. | 310.12 Million USD | -1374.24% |
| ADMA Biologics, Inc. | 193.97 Million USD | -2256.993% |
| Clene Inc. | 38.95 Million USD | -11637.824% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -12553.302% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -1679.154% |
| GeoVax Labs, Inc. | 3.51 Million USD | -129790.755% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -2302.99% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -37437.988% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -2205.342% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -37391.39% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -9403.024% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -8552.372% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -1136.163% |
| Evaxion Biotech A/S | 17.61 Million USD | -25851.498% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -2741.004% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -2884.607% |
| Trevena, Inc. | 48.26 Million USD | -9373.292% |
| Surrozen, Inc. | 8.14 Million USD | -56032.597% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -21071.567% |
| Cingulate Inc. | 10.36 Million USD | -44027.59% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -166154.545% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -12160.002% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -127377.332% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -34668.061% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -1341.357% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -18299.131% |
| Clearmind Medicine Inc. | 3.61 Million USD | -126547.919% |
| Kronos Bio, Inc. | 54.2 Million USD | -8335.269% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -9618.768% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -19988.11% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -22679.134% |
| Statera Biopharma, Inc. | 22.67 Million USD | -20061.883% |
| ImmunityBio, Inc. | 1.09 Billion USD | -319.3% |
| Korro Bio, Inc. | 51.75 Million USD | -8734.441% |
| Kineta, Inc. | 7.22 Million USD | -63206.563% |
| BioVie Inc. | 9.7 Million USD | -47023.673% |
| Codexis, Inc. | 49.94 Million USD | -9053.886% |
| Celularity Inc. | 102.92 Million USD | -4341.897% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -4650.278% |
| Celcuity Inc. | 51.45 Million USD | -8786.284% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -1324372.615% |
| Cibus, Inc. | 206.11 Million USD | -2118.158% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -10663.979% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -17258.29% |
| IN8bio, Inc. | 8.77 Million USD | -52020.383% |
| Kodiak Sciences Inc. | 213.59 Million USD | -2040.54% |
| Annexon, Inc. | 47.11 Million USD | -9603.298% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -5006.041% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -4644.117% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -33299.08% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -75.617% |
| Eyenovia, Inc. | 19.78 Million USD | -23013.93% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -2481.796% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -59423.5% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -18871.742% |
| Arcellx, Inc. | 339.75 Million USD | -1245.687% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -38326.626% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -1762.018% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -47709.265% |
| Moolec Science SA | 13.94 Million USD | -32685.108% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -10495.106% |
| Geron Corporation | 146.12 Million USD | -3028.785% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -8947.732% |
| Royalty Pharma plc | 6.29 Billion USD | 27.4% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -11394.368% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -1552857.48% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -185732.356% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -2317.053% |
| Humacyte, Inc. | 114.67 Million USD | -3886.85% |
| Structure Therapeutics Inc. | 29.05 Million USD | -15637.838% |
| 89bio, Inc. | 59.96 Million USD | -7524.702% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -17176.953% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -382174.247% |
| Genelux Corporation | 8.42 Million USD | -54199.287% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -66586.114% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -3253.898% |
| Notable Labs, Ltd. | 4.42 Million USD | -103175.356% |
| Liquidia Corporation | 73.13 Million USD | -6151.196% |
| Mustang Bio, Inc. | 17.61 Million USD | -25849.259% |
| Immunovant, Inc. | 48.95 Million USD | -9239.189% |
| Quantum-Si incorporated | 26.63 Million USD | -17067.962% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -11811.523% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -147241.283% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -6090.006% |
| Acasti Pharma Inc. | 11.55 Million USD | -39460.44% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -20123.171% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -168086.798% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -12297.972% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -335375.426% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -74900.0% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -18309.503% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -19620.497% |
| PepGen Inc. | 34.63 Million USD | -13102.044% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -37548.221% |
| United Therapeutics Corporation | 1.18 Billion USD | -286.737% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -65363.918% |
| Solid Biosciences Inc. | 38.45 Million USD | -11788.294% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -53328.735% |
| Immuneering Corporation | 12 Million USD | -37973.491% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -1456609.722% |
| Silo Pharma, Inc. | 1.56 Million USD | -291245.658% |
| Belite Bio, Inc | 4.21 Million USD | -108472.786% |
| XOMA Corporation | 145.58 Million USD | -3040.541% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -188203.13% |
| Bionomics Limited | 10.15 Million USD | -44905.666% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -21174.022% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -19853.738% |
| uniQure N.V. | 624.01 Million USD | -632.67% |
| Cassava Sciences, Inc. | 14.19 Million USD | -32108.524% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -2530046.485% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -2586.504% |
| Forte Biosciences, Inc. | 3.66 Million USD | -124613.584% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -1754427.348% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -67663.45% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -59423.5% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -26201.559% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -43162.68% |
| Altimmune, Inc. | 16.54 Million USD | -27540.409% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -640.158% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -19853.738% |
| Compugen Ltd. | 55.77 Million USD | -8097.221% |
| Peak Bio, Inc. | 20.75 Million USD | -21930.163% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -4038.942% |
| Benitec Biopharma Inc. | 4.96 Million USD | -92040.266% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -2796.549% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -5981.89% |
| Zura Bio Limited | 21.29 Million USD | -21372.854% |
| PolyPid Ltd. | 17.46 Million USD | -26073.575% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -3967.652% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -5981.89% |
| Instil Bio, Inc. | 99.8 Million USD | -4481.116% |
| argenx SE | 444.95 Million USD | -927.529% |
| Immunome, Inc. | 28.65 Million USD | -15853.66% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -54739.87% |
| Verona Pharma plc | 58.84 Million USD | -7670.092% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -31489.857% |
| Shattuck Labs, Inc. | 14.85 Million USD | -30669.231% |
| CervoMed Inc. | 2.59 Million USD | -176034.269% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -93703.857% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -35798.241% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -43298.196% |
| Moolec Science SA | 13.94 Million USD | -32685.108% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -194992.477% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -8123.718% |
| AnaptysBio, Inc. | 364.28 Million USD | -1155.058% |
| Design Therapeutics, Inc. | 11.95 Million USD | -38140.214% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -35945.412% |
| NeurAxis, Inc. | 1.91 Million USD | -238928.953% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -11644.76% |
| Lumos Pharma, Inc. | 13.33 Million USD | -34190.857% |
| Achilles Therapeutics plc | 19.08 Million USD | -23853.476% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -31489.857% |
| 180 Life Sciences Corp. | 5.38 Million USD | -84767.693% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -19282.745% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -19988.11% |
| Nutriband Inc. | 1.07 Million USD | -423657.483% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -14842.153% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -31407.133% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -1039.371% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -13979.389% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -34936.91% |
| Palisade Bio, Inc. | 2.73 Million USD | -166822.234% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -86935.979% |
| Beam Therapeutics Inc. | 478.38 Million USD | -855.716% |
| Neurogene Inc. | 36.54 Million USD | -12409.234% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -1048.885% |
| AEON Biopharma, Inc. | 159.88 Million USD | -2759.484% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -9494.963% |
| Sesen Bio, Inc. | 30.98 Million USD | -14656.003% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -17511.032% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -60040.359% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -2235.775% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -2280.543% |
| Athira Pharma, Inc. | 30.05 Million USD | -15111.099% |
| Vaccinex, Inc. | 5.94 Million USD | -76843.79% |
| HCW Biologics Inc. | 15.05 Million USD | -30274.816% |
| XOMA Corporation | 145.58 Million USD | -3040.541% |
| Nektar Therapeutics | 267.04 Million USD | -1612.065% |
| Arvinas, Inc. | 644.6 Million USD | -609.277% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -25682.251% |
| Merus N.V. | 102.15 Million USD | -4375.727% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -3024.018% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -4706.56% |
| Rezolute, Inc. | 11.73 Million USD | -38863.695% |
| Clene Inc. | 38.95 Million USD | -11637.824% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -160468.663% |
| BeyondSpring Inc. | 48.26 Million USD | -9371.918% |
| Synlogic, Inc. | 32.89 Million USD | -13798.769% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -31187.21% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -279704.162% |
| Peak Bio, Inc. | 20.75 Million USD | -21930.163% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -7104.652% |
| Krystal Biotech, Inc. | 39.71 Million USD | -11412.313% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -1113.878% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -4491.791% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -1056457.729% |
| MannKind Corporation | 721.36 Million USD | -533.798% |
| Ikena Oncology, Inc. | 22.33 Million USD | -20370.114% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -219075.455% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -4356.575% |
| Gossamer Bio, Inc. | 249.14 Million USD | -1735.061% |
| CohBar, Inc. | 1.03 Million USD | -442221.199% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -42672.944% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -23902.52% |
| Legend Biotech Corporation | 589.93 Million USD | -675.003% |
| Mural Oncology plc | 37.92 Million USD | -11954.419% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -3347.028% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -199086.871% |
| Disc Medicine, Inc. | 22.87 Million USD | -19886.885% |
| Champions Oncology, Inc. | 28.03 Million USD | -16208.186% |
| REGENXBIO Inc. | 262.22 Million USD | -1643.521% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -135997.676% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -36376.783% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -33939.063% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -21460.953% |
| Vaxart, Inc. | 34.02 Million USD | -13337.179% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -22323.566% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -15924.18% |
| Cellectis S.A. | 249.57 Million USD | -1731.914% |
| Longeveron Inc. | 5.33 Million USD | -85566.105% |
| Repare Therapeutics Inc. | 41.81 Million USD | -10832.83% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -90.085% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -7473.549% |
| Revolution Medicines, Inc. | 262.39 Million USD | -1642.398% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -216890.982% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -52902.55% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -38642.479% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -32457.146% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -212452.301% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 11.22% |
| Denali Therapeutics Inc. | 122.96 Million USD | -3618.192% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -82057.899% |
| Veru Inc. | 32.81 Million USD | -13833.627% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -66459.907% |
| Cingulate Inc. | 10.36 Million USD | -44027.59% |
| Passage Bio, Inc. | 39.26 Million USD | -11544.847% |
| Context Therapeutics Inc. | 4.19 Million USD | -108972.301% |
| Exicure, Inc. | 8.54 Million USD | -53379.939% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -15394.103% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -43500.992% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -20643.16% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -2705.149% |
| Nuvalent, Inc. | 31.82 Million USD | -14266.967% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -71768.407% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -7154.61% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -25300.0% |
| OmniAb, Inc. | 87.4 Million USD | -5131.121% |
| Anew Medical, Inc. | 8.24 Million USD | -55373.326% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -11840.737% |
| Lipocine Inc. | 2.63 Million USD | -173632.696% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -17302.558% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -11269.74% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -17060.995% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -5206.776% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -84550.991% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -5425.276% |
| Ocugen, Inc. | 23.98 Million USD | -18963.503% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -9751.962% |
| Q32 Bio Inc. | 233.12 Million USD | -1861.154% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -50330.179% |
| Alumis Inc. Common Stock | 53.5 Million USD | -8445.475% |
| Equillium, Inc. | 27.95 Million USD | -16253.686% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -2113.058% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -81155.948% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -74447.919% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -2806.068% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -6484.765% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -45738.258% |
| Dominari Holdings Inc. | 4.63 Million USD | -98540.777% |
| Edesa Biotech, Inc. | 1.84 Million USD | -248157.393% |
| vTv Therapeutics Inc. | 29.56 Million USD | -15363.185% |
| Bio-Techne Corporation | 744.34 Million USD | -514.235% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -3525.723% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -1227.31% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -11168.022% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -15688.928% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -4850.195% |
| Nkarta, Inc. | 105.6 Million USD | -4229.545% |
| BioCardia, Inc. | 4.59 Million USD | -99507.843% |
| Iterum Therapeutics plc | 32.66 Million USD | -13897.918% |